Mystery caller study on emergency contraception in Germany!

By João L. Carapinha

June 20, 2023

Researchers examined immediate availability, pricing, and counseling aspects of oral emergency contraception in Berlin pharmacies.
Results included:

✅ Ulipristal acetate prices ranged from €15.95 to €42.95 (median €35.00)
✅ Levonorgestrel prices ranged from €10.60 to €32.49 (median €22.00)

Great access, but high price ranges pose challenges. A comparison app could help minimize costs. Pharmacy staff training is essential for providing “adequate” counseling.

Reference url

Recent Posts

Real-World Evidence Integration into Cancer HTA: Scotland’s Success Story

By João L. Carapinha

April 1, 2026

How is real-world evidence integration a routine part of Health Technology Assessment (HTA) for cancer medicines in Scotland? Through a successful collaboration between the Cancer Medicines Outcomes Programme–Public Health Scotland (CMOP-PHS) and the Scottish Medicines Consortium (SMC), structure...
EU Alzheimer Approval Challenges: Anavex Withdraws Blarcamesine Application Amid Regulatory Hurdles

By João L. Carapinha

March 26, 2026

Anavex Life Sciences has withdrawn its marketing authorization application for blarcamesine in early Alzheimer’s disease following feedback from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP). EU Alzheimer Approval Challenges remain a significant hurdle for ...
NICE Pembrolizumab Recommendation for Locally Advanced Head and Neck Cancer Treatment

By HEOR Staff Writer

March 25, 2026

NICE Pembrolizumab recommendation offers a major advance for adults with resectable locally advanced head and neck squamous cell carcinoma. This update provides an evidence-based overview of the final draft guidance issued by NICE recommending pembrolizumab, within its marketing authorisation, fo...